Kansas Statutes Chapter 65. Public Health § 65-1682. Prescription monitoring program act; definitions

(a) “Audit trail information” means information produced regarding requests for prescription monitoring program data that the board and advisory committee use to monitor compliance with this act.

(b) “Board” means the state board of pharmacy.

(c) “Delegate” means:

(d) “Dispenser” means a practitioner, pharmacy or pharmacist who delivers a scheduled substance or drug of concern to an ultimate user, but does not include:

(e) “Drug of concern” means any drug that demonstrates a potential for abuse and is designated as a drug of concern in rules and regulations promulgated by the board.

(f) “Patient” means the individual who is the ultimate user of a drug for whom a prescription is issued or for whom a drug is dispensed.

(g) “Pharmacist” means an individual currently licensed by the board to practice the profession of pharmacy in this state.

(h) “Pharmacy” means a premises, laboratory, area or other place currently registered with the board where scheduled substances or drugs of concern are offered for sale or dispensed in this state.

(i) “Practitioner” means an individual licensed to practice medicine and surgery, dentist, podiatrist, optometrist or other individual authorized by law to prescribe or dispense scheduled substances and drugs of concern.

(j) “Program” means the prescription monitoring program.

(k) “Scheduled substance” means controlled substances included in schedules II, III or IV of the schedules designated in K.S.A. 65-4107, 65-4109 and 65-4111, and amendments thereto, respectively, or the federal controlled substances act, 21 U.S.C. § 812.